Cano Health, Inc.
CANO · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $669,944 | $4,238,462 | $2,229,324 | $831,217 |
| - Cash | $27,329 | $163,170 | $33,807 | $29,192 |
| + Debt | $1,199,715 | $1,065,284 | $465,188 | $0 |
| Enterprise Value | $1,842,330 | $5,140,576 | $2,660,705 | $802,025 |
| Revenue | $2,738,916 | $1,609,369 | $831,576 | $361,384 |
| % Growth | 70.2% | 93.5% | 130.1% | – |
| Gross Profit | $421,693 | $198,969 | $165,231 | $76,712 |
| % Margin | 15.4% | 12.4% | 19.9% | 21.2% |
| EBITDA | -$197,616 | -$48,617 | -$18,042 | $17,633 |
| % Margin | -7.2% | -3% | -2.2% | 4.9% |
| Net Income | -$428,389 | -$116,737 | -$71,064 | -$29,693 |
| % Margin | -15.6% | -7.3% | -8.5% | -8.2% |
| EPS Diluted | -87.6 | -24.54 | -42.75 | -17.86 |
| % Growth | -257% | 42.6% | -139.4% | – |
| Operating Cash Flow | -$146,337 | -$128,527 | -$9,235 | -$15,465 |
| Capital Expenditures | -$49,529 | -$34,354 | -$12,072 | -$9,310 |
| Free Cash Flow | -$195,866 | -$162,881 | -$21,307 | -$24,775 |